Literature DB >> 10460635

Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test.

C M Lam1, S T Fan, C M Lo, J Wong.   

Abstract

BACKGROUND: Liver failure is the commonest cause of postoperative death in patients with hepatocellular carcinoma (HCC). With the improvement in operative technique and perioperative care, the limit of hepatic functional reserve may be lowered. The aim of this study was to evaluate the postoperative morbidity, mortality and survival rates in patients with an indocyanine green (ICG) retention value higher than 14 per cent, after major hepatectomy for HCC.
METHODS: From January 1994 to December 1997, 117 patients underwent major hepatectomy for HCC; 92 patients had preoperative ICG retention at 15 min lower than 14 per cent (median 8.3 (range 1.6-13.8) per cent), while 25 patients had ICG retention greater than 14 per cent (17.4 (range 14.3-35.3) per cent). Data were collected prospectively and analysed retrospectively.
RESULTS: The two groups of patients were similar in terms of age, sex ratio, preoperative platelet count, liver biochemistry, Child-Pugh status and operative procedures performed, but the prothrombin time was significantly longer in the high ICG group. The operative blood loss (1.5 litres), the amount of blood transfused and the number of patients requiring blood transfusion were similar. The postoperative complication rate (41 versus 40 per cent), duration of hospital stay (12 versus 13 days), hospital mortality rate (1 versus 4 per cent) and median survival time (47 versus 45 months) were not significantly different.
CONCLUSION: With meticulous surgical technique to decrease intraoperative blood loss and good perioperative care, selected patients with limited hepatic functional reserve can achieve a good immediate postoperative result and a survival rate similar to that of patients with good hepatic functional reserve.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460635     DOI: 10.1046/j.1365-2168.1999.01204.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  43 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.

Authors:  Hiroaki Yokomori; Masaya Oda; Kazunori Yoshimura; Sanae Machida; Fumihiko Kaneko; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-08-20       Impact factor: 7.527

Review 3.  Surgical management of hepatocellular carcinoma.

Authors:  Tony Cy Pang; Vincent Wt Lam
Journal:  World J Hepatol       Date:  2015-02-27

Review 4.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

Review 5.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 6.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

7.  Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.

Authors:  Hao Hu; Hong Han; Xi Kun Han; Wen Ping Wang; Hong Ding
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

8.  Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.

Authors:  Jae Hyun Han; Dong Goo Kim; Gun Hyung Na; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver--re-evaluations of microlymphatic abnormalities.

Authors:  Hiroaki Yokomori; Masaya Oda; Fumihiko Kaneko; Shigeyuki Kawachi; Minoru Tanabe; Kazunori Yoshimura; Yuko Kitagawa; Toshifumi Hibi
Journal:  BMC Gastroenterol       Date:  2010-11-08       Impact factor: 3.067

10.  Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives.

Authors:  Shahid G Farid; K Rajendra Prasad; Gareth Morris-Stiff
Journal:  World J Gastrointest Surg       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.